The Rising Concern Over Hepatotoxic Botanicals: What You Need to Know
In the United States, herbal and dietary supplements (HDS) have grown exponentially. These supplements, often marketed as natural remedies to boost health and treat various ailments, have become a staple in many households. However, a recent study published in JAMA Network Open has shed light on a lesser-known risk associated with some of these supplements—potential liver toxicity or hepatotoxicity.
The Study in Focus
The study titled “Estimated Exposure to 6 Potentially Hepatotoxic Botanicals in US Adults,” conducted by Dr Alisa Likhitsup and her colleagues, analyzed data from the National Health and Nutrition Examination Survey (NHANES) to assess the prevalence of six botanicals commonly associated with liver damage. These botanicals are turmeric, green tea extract, Garcinia cambogia, black cohosh, red yeast rice, and ashwagandha. The findings were eye-opening: approximately 4.7% of US adults, or about 15.6 million people, reported using at least one of these potentially hepatotoxic botanicals in the past 30 days.
The Popularity of Hepatotoxic Botanicals
Among the six botanicals studied, turmeric was the most frequently used, followed by green tea extract, ashwagandha, Garcinia cambogia, red yeast rice, and black cohosh. These supplements are widely consumed for various reasons, such as improving joint health, boosting energy, aiding weight loss, and managing menopause symptoms.
Despite their popularity, the study highlights a significant concern: most users of these botanicals were unaware of the potential risks associated with their consumption. The vast majority were taking these supplements without any recommendation from healthcare providers, relying instead on marketing claims and popular belief in the health benefits of these “natural” products.
The Hidden Dangers
Hepatotoxicity refers to liver damage caused by chemical substances. While the liver is a resilient organ, capable of regenerating itself after injury, repeated or severe damage can lead to serious conditions such as hepatitis, cirrhosis, or even liver failure. The study’s authors emphasized that the risk of liver damage from these botanicals is not negligible, particularly given the lack of regulatory oversight in the manufacturing and testing of these products.
For instance, turmeric and green tea extract, while generally considered safe in dietary amounts, have been associated with liver injury in some cases when taken in concentrated forms. Garcinia cambogia, often promoted as a weight loss supplement, has been linked to acute liver failure. Black cohosh, used by women to manage menopausal symptoms, has also been implicated in cases of liver toxicity.
Who Is at Risk?
The study found that users of these potentially hepatotoxic botanicals tend to be older, more educated, and more likely to have chronic conditions such as arthritis. Interestingly, these users were also more likely to take prescription medications, which raises concerns about potential interactions between botanicals and drugs, further complicating liver health.
Moreover, the study revealed that many individuals were consuming multiple HDS products simultaneously, which could increase the risk of adverse effects. For example, users of red yeast rice and ashwagandha were found to consume a median of four different supplements, raising questions about the cumulative impact of these products on liver health.
The Regulatory Gap
One of the key takeaways from the study is the glaring lack of regulatory oversight in the HDS industry. Unlike prescription medications, which undergo rigorous testing for safety and efficacy, dietary supplements are not subject to the same level of scrutiny by the Food and Drug Administration (FDA). This means that the actual contents of these products can vary significantly from what is listed on the label, and their potential effects on the liver are not always well understood.
The study’s authors called for increased regulatory oversight, including mandatory safety testing of HDS products and accurate ingredient labeling. They also urged healthcare providers to take a proactive role in educating patients about the potential risks associated with these supplements, particularly those with known hepatotoxic effects.
What Should Consumers Do?
If you are among the millions of Americans who take herbal supplements, it is important to be aware of the potential risks. Here are a few steps you can take to protect your liver health:
- Consult Your Healthcare Provider: Before starting any new supplement, especially if you are taking prescription medications or have a chronic health condition, talk to your healthcare provider. They can help you assess the potential risks and benefits based on your health needs.
- Research the Supplement: Look for reliable information on the safety and efficacy of the supplement you are considering. Be wary of marketing claims that sound too good to be true, and seek out scientific studies or reviews from reputable sources.
- Watch for Signs of Liver Trouble: If you experience symptoms such as jaundice (yellowing of the skin or eyes), dark urine, fatigue, or unexplained nausea, stop taking the supplement and seek medical attention immediately. These could be signs of liver damage.
- Limit the Use of Multiple Supplements: Taking several supplements simultaneously can increase the risk of interactions and adverse effects. Stick to a few well-researched products that address your specific health needs.
Conclusion
The use of herbal and dietary supplements is widespread, and many people assume that because these products are “natural,” they are also safe. However, as the study by Dr. Likhitsup and colleagues illustrates, this is not always the case. Certain botanicals can pose a real risk to liver health, particularly when taken in concentrated forms or in combination with other supplements and medications.
As consumers, it is crucial to approach these products cautiously and seek guidance from healthcare professionals. At the same time, there is a pressing need for more robust regulation and oversight of the HDS industry to ensure these products are safe and accurately labelled. Only then can consumers make truly informed decisions about their health.
2.
Mishra S, Stierman B, Gahche JJ, Potischman N. Dietary Supplement Use Among Adults: United States, 2017–2018. NCHS Data Brief, No. 399. National Center for Health Statistics; 2021.
3.
Navarro V, Avula B, Khan I, et al. The contents of herbal and dietary supplements implicated in liver injury in the United States are frequently mislabeled. Hepatol Commun. 2019;3(6):792-794. doi:10.1002/hep4.1346PubMedGoogle ScholarCrossref
4.
Avigan MI, Mozersky RP, Seeff LB. Scientific and regulatory perspectives in herbal and dietary supplement associated hepatotoxicity in the United States. Int J Mol Sci. 2016;17(3):331. doi:10.3390/ijms17030331PubMedGoogle ScholarCrossref
11.
Vuppalanchi R, Bonkovsky HL, Ahmad J, et al; Drug-Induced Liver Injury Network. Garcinia cambogia, either alone or in combination with green tea, causes moderate to severe liver injury. Clin Gastroenterol Hepatol. 2022;20(6):e1416-e1425. doi:10.1016/j.cgh.2021.08.015PubMedGoogle ScholarCrossref
14.
Hillman L, Gottfried M, Whitsett M, et al. Clinical features and outcomes of complementary and alternative medicine induced acute liver failure and injury. Am J Gastroenterol. 2016;111(7):958-965. doi:10.1038/ajg.2016.114PubMedGoogle ScholarCrossref
15.
National Institutes of Health Office of Dietary Supplements. Dietary Supplement Label Database (DSLD). Accessed July 1, 2023. https://dsld.od.nih.gov/
16.
Zipf G, Chiappa M, Porter KS, Ostchega Y, Lewis BG, Dostal J. National Health and Nutrition Examination Survey: plan and operations, 1999-2010. Vital Health Stat 1. 2013;(56):1-37.
17.
Stierman B, Afful J, Carroll MD, et al. National Health and Nutrition Examination Survey 2017–March 2020 Prepandemic Data Files—Development of Files and Prevalence Estimates for Selected Health Outcomes. National Health Statistics Reports; No. 158. National Center for Health Statistics; 2021.
23.
National Institute of Diabetes and Digestive and Kidney Diseases. LiverTox: clinical and research information on drug-induced liver injury, 2012-. Updated June 20, 2024. Accessed January 19, 2024. https://www.ncbi.nlm.nih.gov/books/NBK547852/
25.
US Food and Drug Administration. Dietary Supplement Health and Education Act of 1994; Public Law 103–417. US Food and Drug Administration; 1994.
26.
Gahche JJ, Bailey RL, Potischman N, et al. Federal monitoring of dietary supplement use in the resident, civilian, noninstitutionalized US population, National Health and Nutrition Examination Survey. J Nutr. 2018;148(suppl 2):1436S-1444S. doi:10.1093/jn/nxy093PubMedGoogle ScholarCrossref
28.
Farina EK, Austin KG, Lieberman HR. Concomitant dietary supplement and prescription medication use is prevalent among US adults with doctor-informed medical conditions. J Acad Nutr Diet. 2014;114(11):1784-90.e2. doi:10.1016/j.jand.2014.01.016PubMedGoogle ScholarCrossref
32.
Chalasani N, Fontana RJ, Bonkovsky HL, et al; Drug Induced Liver Injury Network (DILIN). Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology. 2008;135(6):1924-1934, 1934.e1-1934.e4. doi:10.1053/j.gastro.2008.09.011PubMedGoogle ScholarCrossref
34.
Centers for Disease Control and Prevention (CDC). Notes from the field: acute hepatitis and liver failure following the use of a dietary supplement intended for weight loss or muscle building—May-October 2013. MMWR Morb Mortal Wkly Rep. 2013;62(40):817-819.PubMedGoogle Scholar
35.
Bonkovsky HL, Kleiner DE, Gu J, et al; U.S. Drug Induced Liver Injury Network Investigators. Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements. Hepatology. 2017;65(4):1267-1277. doi:10.1002/hep.28967PubMedGoogle ScholarCrossref
37.
Kesar V, Channen L, Masood U, et al. Liver transplantation for acute liver injury in Asians is more likely due to herbal and dietary supplements. Liver Transpl. 2022;28(2):188-199. doi:10.1002/lt.26260PubMedGoogle ScholarCrossref
40.
O’Connor EA, Evans CV, Ivlev I, et al. Vitamin and mineral supplements for the primary prevention of cardiovascular disease and cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2022;327(23):2334-2347. doi:10.1001/jama.2021.15650
ArticlePubMedGoogle ScholarCrossref
41.
Mangione CM, Barry MJ, Nicholson WK, et al; US Preventive Services Task Force. Vitamin, mineral, and multivitamin supplementation to prevent cardiovascular disease and cancer: US Preventive Services Task Force recommendation statement. JAMA. 2022;327(23):2326-2333. doi:10.1001/jama.2022.8970
ArticlePubMedGoogle ScholarCrossref
42.
Radimer K, Bindewald B, Hughes J, Ervin B, Swanson C, Picciano MF. Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. Am J Epidemiol. 2004;160(4):339-349. doi:10.1093/aje/kwh207PubMedGoogle ScholarCrossref
44.
Patterson RE, Neuhouser ML, Hedderson MM, Schwartz SM, Standish LJ, Bowen DJ. Changes in diet, physical activity, and supplement use among adults diagnosed with cancer. J Am Diet Assoc. 2003;103(3):323-328.PubMedGoogle Scholar
45.
Miller MF, Bellizzi KM, Sufian M, Ambs AH, Goldstein MS, Ballard-Barbash R. Dietary supplement use in individuals living with cancer and other chronic conditions: a population-based study. J Am Diet Assoc. 2008;108(3):483-494. doi:10.1016/j.jada.2007.12.005PubMedGoogle ScholarCrossref
49.
Zeng L, Yang T, Yang K, et al. Efficacy and safety of curcumin and Curcuma longa extract in the treatment of arthritis: a systematic review and meta-analysis of randomized controlled trial. Front Immunol. 2022;13:891822. doi:10.3389/fimmu.2022.891822PubMedGoogle ScholarCrossref
51.
Rondanelli M, Riva A, Petrangolini G, et al. Effect of acute and chronic dietary supplementation with green tea catechins on resting metabolic rate, energy expenditure and respiratory quotient: a systematic review. Nutrients. 2021;13(2):644. doi:10.3390/nu13020644PubMedGoogle ScholarCrossref
53.
Mena-García A, Bellaizac-Riascos AJ, Rada-Mendoza M, Chito-Trujillo DM, Ruiz-Matute AI, Sanz ML. Quality Evaluation of dietary supplements for weight loss based on Garcinia cambogia. Nutrients. 2022;14(15):3077. doi:10.3390/nu14153077PubMedGoogle ScholarCrossref
56.
Nahin RL, Pecha M, Welmerink DB, Sink K, DeKosky ST, Fitzpatrick AL; Ginkgo Evaluation of Memory Study Investigators. Concomitant use of prescription drugs and dietary supplements in ambulatory elderly people. J Am Geriatr Soc. 2009;57(7):1197-1205. doi:10.1111/j.1532-5415.2009.02329.xPubMedGoogle ScholarCrossref
Leave A Comment